<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Modular Medical Inc — News on 6ix</title>
<link>https://6ix.com/company/modular-medical-inc</link>
<description>Latest news and press releases for Modular Medical Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Sun, 19 Apr 2026 23:50:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/modular-medical-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68359c2878dffbe2df1070ac.webp</url>
<title>Modular Medical Inc</title>
<link>https://6ix.com/company/modular-medical-inc</link>
</image>
<item>
<title>Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-pricing-of-dollar34-million-registered-direct-offering-of-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-pricing-of-dollar34-million-registered-direct-offering-of-common-stock</guid>
<pubDate>Sun, 19 Apr 2026 23:50:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the ...</description>
</item>
<item>
<title>Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-regains-compliance-with-nasdaq-minimum-bid-price-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-regains-compliance-with-nasdaq-minimum-bid-price-requirement</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative,</description>
</item>
<item>
<title>Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-fda-510k-clearance-for-pivot-tubeless-insulin-patch-pump</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-fda-510k-clearance-for-pivot-tubeless-insulin-patch-pump</guid>
<pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
<description>First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment.Key Milestones & Investment Highlights:FDA</description>
</item>
<item>
<title>Modular Medical Announces 1-for-30 Reverse Stock Split</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-1-for-30-reverse-stock-split</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-1-for-30-reverse-stock-split</guid>
<pubDate>Thu, 26 Mar 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery</description>
</item>
<item>
<title>Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-dollar120-million-public-offering-priced-at-a-premium-to-market</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-dollar120-million-public-offering-priced-at-a-premium-to-market</guid>
<pubDate>Tue, 03 Mar 2026 14:27:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" ...</description>
</item>
<item>
<title>Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-achieves-key-manufacturing-133000481</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-achieves-key-manufacturing-133000481</guid>
<pubDate>Wed, 04 Feb 2026 13:30:00 GMT</pubDate>
<description>Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot ...</description>
</item>
<item>
<title>Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-180-day-133000475</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-180-day-133000475</guid>
<pubDate>Wed, 31 Dec 2025 13:30:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult ...</description>
</item>
<item>
<title>Modular Medical Announces Pricing of $4.68 Million Public Offering</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-pricing-4-134000702</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-pricing-4-134000702</guid>
<pubDate>Wed, 10 Dec 2025 13:40:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult ...</description>
</item>
<item>
<title>Modular Medical Announces Proposed Public Offering</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-proposed-public-221500321</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-proposed-public-221500321</guid>
<pubDate>Tue, 09 Dec 2025 22:15:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with ...</description>
</item>
<item>
<title>Modular Medical Announces Proposed Public Offering </title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-proposed-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-proposed-public-offering</guid>
<pubDate>Tue, 09 Dec 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the</description>
</item>
<item>
<title>Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-irb-approval-133000205</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-irb-approval-133000205</guid>
<pubDate>Mon, 17 Nov 2025 13:30:00 GMT</pubDate>
<description>Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery ...</description>
</item>
<item>
<title>Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-submits-pivot-tubeless-140000932</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-submits-pivot-tubeless-140000932</guid>
<pubDate>Fri, 14 Nov 2025 14:00:00 GMT</pubDate>
<description>-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump - Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA / ACCESS Newswire / November 14, 2025 / Modular ...</description>
</item>
<item>
<title>Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-successful-validation-133000518</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-successful-validation-133000518</guid>
<pubDate>Mon, 03 Nov 2025 13:30:00 GMT</pubDate>
<description>Key Highlights: Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...</description>
</item>
<item>
<title>Modular Medical Announces Ongoing Progress to Obtain CE Mark</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-ongoing-progress-123000883</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-ongoing-progress-123000883</guid>
<pubDate>Tue, 28 Oct 2025 12:30:00 GMT</pubDate>
<description>Key Highlights: Pivot continues to progress toward CE Mark certification in 2026 Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 /Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" ...</description>
</item>
<item>
<title>Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-appoints-david-bosshard-123000541</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-appoints-david-bosshard-123000541</guid>
<pubDate>Mon, 06 Oct 2025 12:30:00 GMT</pubDate>
<description>-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA / ACCESS Newswire / October 6, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" ...</description>
</item>
<item>
<title>Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-exercise-warrants-120000972</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-exercise-warrants-120000972</guid>
<pubDate>Mon, 29 Sep 2025 12:00:00 GMT</pubDate>
<description>SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today ...</description>
</item>
<item>
<title>Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-irb-approval-120000614</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-receives-irb-approval-120000614</guid>
<pubDate>Mon, 15 Sep 2025 12:00:00 GMT</pubDate>
<description>-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin ...</description>
</item>
<item>
<title>Modular Medical Announces Completion of Clinical Study of MODD1 Pump</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-completion-clinical-200500291</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-completion-clinical-200500291</guid>
<pubDate>Thu, 11 Sep 2025 20:05:00 GMT</pubDate>
<description>- Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...</description>
</item>
<item>
<title>Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-completion-modd1-120000539</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-completion-modd1-120000539</guid>
<pubDate>Tue, 26 Aug 2025 12:00:00 GMT</pubDate>
<description>-More than 6,000 MODD1 cartridges produced - Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), ...</description>
</item>
<item>
<title>Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration</title>
<link>https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-next-generation-120000698</link>
<guid isPermaLink="true">https://6ix.com/company/modular-medical-inc/news/modular-medical-announces-next-generation-120000698</guid>
<pubDate>Fri, 08 Aug 2025 12:00:00 GMT</pubDate>
<description>-Debuting a "coming soon" campaign for tubeless Pivot patch pump - Expects special 510(k) filing for Pivot product in October - Will introduce first level of its gamified training application developed by Level Ex, developers of the Level One diabetes-management ...</description>
</item>
</channel>
</rss>